Blinded End Point Adjudication in the ‘Danish Multicenter Randomized Study on Fibrinolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction’ (DANAMI-2 Trial)

Publisher： Karger

E-ISSN： 1424-0556|3|3|127-133

ISSN： 1422-9528

Source： Heart Drug, Vol.3, Iss.3, 2003-11, pp. : 127-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Pharmacodynamics of Tenecteplase in Fibrinolytic Therapy of Acute Myocardial Infarction

By Tanswell P.  

Clinical Pharmacokinetics, Vol. 41, Iss. 15, 2002-01 ,pp. : 1229-1245

Adis International

Access to resources Recommend Favorite

New Approaches to Treatment of Acute Myocardial Infarction: Combination Antiplatelet and Fibrinolytic Therapy

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 192-200

Karger

Access to resources Recommend Favorite

Thrombolysis Versus Primary Angioplasty in Older Patients with Acute Myocardial Infarction

By Maynard C.  

Drugs & Aging, Vol. 14, Iss. 6, 1999-06 ,pp. : 427-435

Adis International

Access to resources Recommend Favorite

Optimizing Reperfusion Therapy: Adjunct Use of Glycoprotein IIb/IIIa Antagonists with Fibrinolytic Therapy in Acute Myocardial Infarction

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 52-55

Karger

Access to resources Recommend Favorite

Adjunctive Use of Direct Thrombin Inhibitors in Patients Receiving Fibrinolytic Therapy for Acute Myocardial Infarction

By French John K.   Edmond John J.  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 107-115

Adis International

Access to resources Recommend Favorite